The conundrum of COVID-19 treatment targets: The close correlation with rheumatology. Response to: Ͽ Management of rheumatic diseases in the time of covid-19 pandemic: Perspectives of rheumatology pracitioners from India' by Gupta et al and Antirheumatic agents in covid-19: Is IL-6 the right target?' by Capeechi et al

Sara Monti; Carlomaurizio Montecucco

doi:10.1136/annrheumdis-2020-217545

The conundrum of COVID-19 treatment targets: The close correlation with rheumatology. Response to: Ͽ Management of rheumatic diseases in the time of covid-19 pandemic: Perspectives of rheumatology pracitioners from India' by Gupta et al and Antirheumatic agents in covid-19: Is IL-6 the right target?' by Capeechi et al

IRCCS Fondazione Policlinico San Matteo

Research output: Contribution to journal › Letter › peer-review

Original language	English
Journal	Annals of the Rheumatic Diseases
DOIs	https://doi.org/10.1136/annrheumdis-2020-217545
Publication status	Accepted/In press - Jan 1 2020

Keywords

arthritis, rheumatoid
immune system diseases
inflammation

ASJC Scopus subject areas

Immunology and Allergy
Rheumatology
Immunology
Biochemistry, Genetics and Molecular Biology(all)

Access to Document

10.1136/annrheumdis-2020-217545

Cite this

Monti, S., & Montecucco, C. (Accepted/In press). The conundrum of COVID-19 treatment targets: The close correlation with rheumatology. Response to: Ͽ Management of rheumatic diseases in the time of covid-19 pandemic: Perspectives of rheumatology pracitioners from India' by Gupta et al and Antirheumatic agents in covid-19: Is IL-6 the right target?' by Capeechi et al. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2020-217545

The conundrum of COVID-19 treatment targets : The close correlation with rheumatology. Response to: Ͽ Management of rheumatic diseases in the time of covid-19 pandemic: Perspectives of rheumatology pracitioners from India' by Gupta et al and Antirheumatic agents in covid-19: Is IL-6 the right target?' by Capeechi et al. / Monti, Sara ; Montecucco, Carlomaurizio.

In: Annals of the Rheumatic Diseases, 01.01.2020.

Research output: Contribution to journal › Letter › peer-review

Monti, S & Montecucco, C 2020, 'The conundrum of COVID-19 treatment targets: The close correlation with rheumatology. Response to: Ͽ Management of rheumatic diseases in the time of covid-19 pandemic: Perspectives of rheumatology pracitioners from India' by Gupta et al and Antirheumatic agents in covid-19: Is IL-6 the right target?' by Capeechi et al', Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2020-217545

Monti S , Montecucco C. The conundrum of COVID-19 treatment targets: The close correlation with rheumatology. Response to: Ͽ Management of rheumatic diseases in the time of covid-19 pandemic: Perspectives of rheumatology pracitioners from India' by Gupta et al and Antirheumatic agents in covid-19: Is IL-6 the right target?' by Capeechi et al. Annals of the Rheumatic Diseases. 2020 Jan 1. https://doi.org/10.1136/annrheumdis-2020-217545

Monti, Sara ; Montecucco, Carlomaurizio. / The conundrum of COVID-19 treatment targets : The close correlation with rheumatology. Response to: Ͽ Management of rheumatic diseases in the time of covid-19 pandemic: Perspectives of rheumatology pracitioners from India' by Gupta et al and Antirheumatic agents in covid-19: Is IL-6 the right target?' by Capeechi et al. In: Annals of the Rheumatic Diseases. 2020.

@article{8e327f3730404a3f893922bdc7cdace6,

title = "The conundrum of COVID-19 treatment targets: The close correlation with rheumatology. Response to: Ͽ Management of rheumatic diseases in the time of covid-19 pandemic: Perspectives of rheumatology pracitioners from India' by Gupta et al and Antirheumatic agents in covid-19: Is IL-6 the right target?' by Capeechi et al",

keywords = "arthritis, rheumatoid, immune system diseases, inflammation",

author = "Sara Monti and Carlomaurizio Montecucco",

year = "2020",

month = jan,

day = "1",

doi = "10.1136/annrheumdis-2020-217545",

language = "English",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - The conundrum of COVID-19 treatment targets

T2 - The close correlation with rheumatology. Response to: Ͽ Management of rheumatic diseases in the time of covid-19 pandemic: Perspectives of rheumatology pracitioners from India' by Gupta et al and Antirheumatic agents in covid-19: Is IL-6 the right target?' by Capeechi et al

AU - Monti, Sara

AU - Montecucco, Carlomaurizio

PY - 2020/1/1

Y1 - 2020/1/1

KW - arthritis, rheumatoid

KW - immune system diseases

KW - inflammation

UR - http://www.scopus.com/inward/record.url?scp=85085097425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85085097425&partnerID=8YFLogxK

U2 - 10.1136/annrheumdis-2020-217545

DO - 10.1136/annrheumdis-2020-217545

M3 - Letter

AN - SCOPUS:85085097425

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

ER -

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this